Tag:
hypoactive sexual desire disorder
Latest Headlines
Latest Headlines
FDA panel review looms for controversial libido drug
The first time researchers studied flibanserin, they thought they had a potential new depression therapy on their hands. That approach failed. But now Boehringer Ingelheim is preparing to make the
Boehringer bets on female libido drug
Germany's Boehringer Ingelheim has high hopes for its experimental female libido booster flibanserin. The treatment, which addresses hypoactive sexual desire disorder, or HSDD, has completed Phase
